Skip to content
Try Mental Wellness – Lifestyle
Author:
Immunogenesis Inc.
ImmunoGenesis to Present IND-Enabling Development Progress and Therapeutic Potential of IMGS-203, a Novel STING Agonist, at SITC 2026 Annual Meeting
November 4, 2026
ImmunoGenesis Announces Appointment of Reza Mazhari and Mike Davis to Its Board of Directors
September 9, 2026
ImmunoGenesis Appoints Chief Medical Officer
May 28, 2026